NYSE:RVTYLife Sciences
Are Revvity’s Slowing Organic Gains Quietly Rewriting Its Margin-Led Growth Story (RVTY)?
In the past few days, commentary on Revvity (formerly PerkinElmer) has highlighted weak organic revenue growth and falling adjusted operating profits, pointing to a business under strain.
An additional concern is that earnings per share have slipped each year over the last five years, suggesting profitability has been consistently deteriorating even though the company remains in the black.
We’ll now explore how Revvity’s ongoing organic growth challenges could reshape its pre-existing...